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S U M M A R Y
Two cases of mixed infection involving Kerstersia gyiorum causing chronic suppurative otitis media
(CSOM) have been reported worldwide. We report, for the ﬁrst time, two cases of CSOM due to mixed
infections involving K. gyiorum in adults in Africa. Both isolates were intermediate susceptible to
ciproﬂoxacin based on European Committee on Antimicrobial Susceptibility Testing (EUCAST)
breakpoints.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Chronic suppurative otitis media (CSOM) is deﬁned as ear
discharge/otorrhea for more than 6 weeks in the presence of
tympanic membrane perforation. The aetiological pattern shows
mixed infections of Gram-negative, Gram-positive, aerobe, and
anaerobe bacteria. Several studies worldwide have reported that
the most common microorganisms isolated are Pseudomonas spp
and Staphylococcus aureus, followed by Gram-negative bacteria
such as Proteus spp, Klebsiella spp, Escherichia spp, and Haemophilus
inﬂuenzae.1 The most frequently isolated anaerobic organisms are
Bacteroides spp and Fusobacterium spp.
Mixed infections have generally been observed in the patho-
genesis of CSOM. The role of some bacteria in the aetiology of
CSOM has not been well studied.1 Recently, newly discovered
pathogens such as Kerstersia gyiorum have been found to be
involved.2,3 The genus Kerstersia was ﬁrst identiﬁed in 2003, about
11 years ago, by Coenye et al.4 The word ‘gyiorum’, meaning ‘from
the limbs’, was given as a species name since the organism was* Corresponding author.
E-mail address: mmmirambo@gmail.com (M.M. Mirambo).
http://dx.doi.org/10.1016/j.ijid.2014.10.022
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).isolated from wound swabs from limbs. Since then, only two cases
of this organism causing CSOM have been reported worldwide. We
report, for the ﬁrst time, two cases of CSOM caused by this
organism occurring in one centre in Africa.
2. Case reports
2.1. Case 1
The ﬁrst patient was a male aged 53 years from rural Mwanza.
He reported having a left ear discharge for the past 2.6 years
without any other symptoms. The patient had been a smoker and
alcoholic for a long time. He was non-diabetic and his HIV status
was not known; after counselling, he refused HIV testing.
On examination the patient was found to have conductive
hearing loss. The patient reported having used various ear drops,
including traditional medicine, without success. He could not
remember the types of ear drops used. An ear swab was taken.
On Gram staining, the sample revealed Gram-negative rods and
few polymorphonuclear cells. Signiﬁcant growth of two morpho-
logically different non-lactose fermenter colonies was observed on
MacConkey agar. The ﬁrst were large colourless colonies that were
indole-negative, urease-positive, and swarming on blood agar andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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mirabilis. The second were medium-sized, light purple in colour,
oxidase-negative, indole-negative, catalase-positive, and non-
motile. No deﬁnitive identiﬁcation was reached for the second
colonies using these in-house biochemical tests. Further testing
using a VITEK 2 Gram-negative identiﬁcation (GNI) card (bioMe´r-
ieux, Durham, NC, USA) gave a negative result. The colonies were
later identiﬁed as K. gyiorum by matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS)
(Bruker MALDI BioTyper system software version 3.1).
Susceptibility testing was done using VITEK 2 (bioMe´rieux,
France). The P. mirabilis was sensitive to ampicillin/sulbactam,
piperacillin/tazobactam, cefotaxime, ceftazidime, ciproﬂoxacin,
trimethoprim/sulfamethoxazole, gentamicin, imipenem, and mer-
openem, while the K. gyiorum had intermediate sensitivity to
ciproﬂoxacin (1 mg/ml) and full sensitivity to piperacillin, cefotax-
ime, ceftazidime, gentamicin, imipenem, meropenem, and moxi-
ﬂoxacin, using the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) non-species-related breakpoints.
The ciproﬂoxacin minimum inhibitory concentration (MIC) of
1 mg/ml is considered susceptible using Clinical and Laboratory
Standards Institute (CLSI) breakpoints.
The patient was treated with ciproﬂoxacin ear drops, which
were initiated before culture and sensitivity results were obtained.
He was scheduled for follow-up 3, 5, and 7 weeks later, but did not
return for these scheduled visits. On telephone consultation, he
reported doing ﬁne and the drainage had stopped after 10 weeks of
treatment. No further complications were noted. After 12 weeks,
he reported doing ﬁne without any complications.
2.2. Case 2
The second patient was a male aged 33 years, not related to the
patient in case 1 above, who presented with an ear discharge of
1.6 years duration involving the right ear. This patient was seen
3 months after the ﬁrst case. The patient was a non-smoker and
was non-diabetic and HIV-negative. He did not have a history of
alcoholism. On examination, conductive hearing loss was found.
The patient had used chloramphenicol ear drops several times
without success. An ear swab was taken.
On Gram staining, Gram-negative rods mixed with a few
Gram-positive cocci were seen. Signiﬁcant growth of three
different colonies was seen on blood agar. Beta-hemolytic golden
yellow colonies were identiﬁed as S. aureus using DNAse and the
coagulase test. Signiﬁcant growth of lactose fermenter and non-
lactose fermenter colonies was seen on MacConkey agar. The
lactose fermenter colonies were identiﬁed as Escherichia coli
using an in-house biochemical test, while no clear identiﬁcation
was obtained for the non-lactose fermenter colonies. The non-
lactose fermenter colonies were oxidase-negative, indole-nega-
tive, catalase-positive, and non-motile. As for case 1, further
identiﬁcation using a VITEK 2 GNI card (bioMe´rieux) gave a
negative result. The colonies were later identiﬁed as K. gyiorum
using MALDI-TOF MS (Bruker MALDI BioTyper system software
version 3.1).
On VITEK 2 susceptibility testing, the S. aureus was resistant to
ampicillin, trimethoprim/sulfamethoxazole, rifampin, and tetra-
cycline and was methicillin-sensitive. The E. coli had an extended-
spectrum beta-lactamase (ESBL) phenotype and was resistant to
ampicillin, sulbactam, piperacillin/tazobactam, cefotaxime, cefta-
zidime, ciproﬂoxacin, and trimethoprim/sulfamethoxazole, and
was intermediate resistant to gentamicin and sensitive to
imipenem and meropenem. The sensitivity test results for this
isolate of K. gyiorum were identical to those of case 1.
Ciproﬂoxacin ear drops were started before culture results were
obtained and the patient was scheduled for follow-up 3, 5, and7 weeks later. He was doing ﬁne at the subsequent visits and the
drainage had stopped.
3. Discussion
Information on the aetiology of CSOM is limited in Africa; this
may be attributed to poor diagnostic facilities. There is the
possibility that various pathogens are involved in the pathogenesis
of CSOM in Africa. In Africa, including Tanzania, most clinical
microbiology laboratories have limited identiﬁcation capacity.
This might result in misidentiﬁcation or failure to identify common
isolates causing certain pathologies. The description of these two
cases in Tanzania with microbial identiﬁcation conﬁrmed using
MALDI-TOF MS shows the importance of advanced technologies in
the identiﬁcation of novel and rare pathogens from clinical
specimens. In developing countries where few biochemical tests
are used for identiﬁcation, this organism might have been
misidentiﬁed. K. gyiorum strains exhibit some features of
Acinetobacter spp, which are also non-fermentative Gram-negative
rods and oxidase-negative. The organism is also closely related to
other members of the genera Alcaligenes5 and Achromobacter.
K. gyiorum may represent an underappreciated cause of CSOM
worldwide as evidenced by the fact that, in the past 2 years, two
cases of CSOM caused by K. gyiorum have been reported, one in the
USA and one in South America.2,3 As previously documented,2,3
both patients had CSOM involving K. gyiorum mixed with other
organisms. It is likely that K. gyiorum has an afﬁnity towards
causing infections in patients with chronic mixed infections.
However, little is known regarding how the organism contributes
to the chronicity of the infected sites, and its virulence factors are
yet to be identiﬁed.
One of the cases presented here was a chronic smoker and an
alcoholic; these factors were reported in one of the previous
cases.3 More studies are needed to establish the role of these
factors in the pathogenesis of this particular infection. These two
isolates had intermediate resistance to ciproﬂoxacin based on
EUCAST breakpoints; one of the two previously reported isolates
from CSOM was resistant to ciproﬂoxacin based on CLSI break-
points3 and the other was fully susceptible to ciproﬂoxacin based
on CLSI breakpoints.2
We have reported these rare cases to alert clinicians to the fact
that K. gyiorum could contribute signiﬁcantly as a possible
aetiology of CSOM in adults. The identiﬁcation of this pathogen
requires advanced techniques, which are limited in developing
countries. There is a need to establish simple molecular techniques
for the identiﬁcation of bacteria in developing countries. This will
reduce misidentiﬁcation of common pathogens involved in various
pathologies in resource-limited countries.
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